GLEN IPO
Marc Stad set to become Timberwolves’ controlling owner in $4.5 billion deal
Marc Stad is set to become the controlling owner of the Timberwolves and Lynx. This significant deal values the franchises at an impressive $4.5 billion. Marc Lore will reduce his involvement and remain a minority investor in the teams. Alex Rodriguez is expected to increase his ownership stake under the new arrangement. The transaction awaits NBA Board of Governors approval before finalization.
From 320% multibagger to 44% underperformer, how Mukul Agrawal’s 2025-26 IPO bets are playing out
Ace investor Mukul Agrawal's 2025-26 IPO investments reveal a bold investment strategy. Several small and medium enterprise listings delivered massive returns, turning into multibaggers. However, some mainboard and SME stocks also experienced significant drops. His portfolio highlights the general trends in newly listed companies without digging deeper into the reasons of gains or declines.
Glen Industries shares list at 62% premium over IPO price on BSE SME platform
Glen Industries made a strong debut on the BSE SME platform. Shares listed at Rs 157, a significant jump over the IPO price. The IPO was oversubscribed by a large margin, attracting strong interest from various investor categories. The company manufactures eco-friendly food packaging. Glen Industries recently expanded its operations and reported substantial profit growth for FY25.
Glen Industries shares list at 62% premium over IPO price on BSE SME platform
Glen Industries' shares debuted at Rs 157 on the BSE SME platform, a 61.86% premium over the IPO price. The IPO was oversubscribed by 260.28 times, driven by strong NII demand. The company, which manufactures eco-friendly food packaging, reported a 113% YoY jump in net profit for FY25, fueled by expansion and robust operating leverage.
IPO Calendar: 3 new issues eye Rs 3,600 crore as primary market momentum continues
Three IPOs—Anthem Biosciences, Spunweb Nonwoven, and Monika Alcobev—aim to raise over Rs 3,600 crore in the week starting July 14. With strong retail interest and sectoral momentum, investor focus remains high. Upcoming listings and grey market trends will guide sentiment amid keen interest in pharma, textiles, and liquor distribution.
Q1 earnings, FII activity among 7 factors that may impact D-Street action this week
Indian markets experienced a downturn due to global tariff uncertainties and a lackluster earnings season start. The Nifty slipped below its 20-day EMA, entering a consolidation phase. Investors will closely monitor Q1 earnings from major companies, domestic inflation data, global events, IPO activity, FII flows, technical indicators, and rupee movement for market direction.
- Go To Page 1
Glen Industries IPO: GMP at 21% on last day of bidding. Check subscription status, other details
Glen Industries IPO: As of 10:05 a.m. today, the offering has received an overall subscription of 16.45 times, reflecting strong interest across all investor categories.
Glen Industries IPO GMP at 31% as issue gets subscribed over 6 times on day 2, so far
Glen Industries' IPO saw strong demand, with a 31% grey market premium and over six times subscription. The company aims to raise Rs 63 cr to build a new plant in West Bengal. With strong FY25 earnings and global clientele, Glen targets Rs 1,000 crore revenue by 2030.
Glen Industries IPO opens today. Check GMP, price band and other details
Glen Industries is launching its IPO on July 8, aiming to raise Rs 63.02 crore. The IPO price is set between Rs 92 and Rs 97 per share. The company plans to use the funds to establish a new manufacturing unit in West Bengal. Glen Industries focuses on eco-friendly packaging and targets Rs 1,000 crore revenue by 2030.
Glen Industries IPO to open on July 8; fixes issue price band at Rs 92-97 per share
Kolkata-based Glen Industries on Monday said it has fixed a price band at Rs 92-97 per share for its Rs 63.02 crore initial share sale that will open for public subscription on July 8.
Trump tariffs, TCS Q1 earnings among 9 factors that’ll steer D-Street this week
Nifty weekly performance: Indian markets ended the week on a cautious note, with the Nifty slipping 0.7% amid profit booking and global uncertainty. While easing inflation and lower interest rates may support sentiment, investors remain watchful of the July 9 U.S. tariff deadline. FIIs turned cautious, though DIIs lent stability. Trade-sensitive sectors like IT and auto are expected to stay in focus.
Swiggy launches new service Bolt to deliver food in 10-15 minutes
For now, a limited set of food items from select restaurants will be on offer. According to CEO Rohit Kapoor, the service is being rolled out in Bengaluru, Hyderabad, Mumbai, Chennai, Delhi, and Pune.
2 pharma stocks that could do well after correction
Sun Pharma and Dr Reddy’s should do reasonably well from current levels, says Sandip Sabharwal.
What will happen to the ride-hailing business model? LinkedIn co-founder Chris Yeh answers
TOI spoke to Yeh, who is also an investor now, during his recent visit to India about where the blitzscaling philosophy works and where it doesn’t, the impact of troubled SoftBank Vision Fund, and future of industries like ride hailing.
Crown prince's clever post-oil math behind Saudi Arabia's radical change of face
Analysts say Prince Salman does seem to have a long-term vision of a more socially and economically liberal kingdom that could become a regional business hub.
Saudis to spend Aramco cash at home after reversing budget cuts
Aramco share-sale is due to take place next year. Without it, the kingdom could take decades to develop its economy and new industries.
Saudi Arabia's Prince Salman needs to do these 6 things to keep his kingdom up and running
Saudi Arabia’s Deputy Crown Prince has a daunting to-do list to transform the world’s biggest oil exporter into an economy no longer reliant on crude.
Indian biotech industry at critical juncture, global biotech stabilizes: Report
Indian biotech industry at critical junction, while global biotech industry showed a 2nd straight yr of increasingly stable financial performance in 2011.
Glenmark Generics files for IPO
Glenmark Generics, the generics arm of Glenmark Pharmaceuticals, on Wednesday filed the draft prospectus with Sebi to raise Rs 550-600 crore from the primary market.
Glenmark Pharma looks to out-license two molecules this year
Glenmark Pharmaceuticals on Friday said it would look at out-licensing two of its molecules this year that are in clinical trials.
Load More
